Meristem Family Wealth’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$363K Sell
1,603
-552
-26% -$130K 0.04% 237
2021
Q4
$582K Hold
2,155
0.05% 202
2021
Q3
$521K Buy
2,155
+6
+0.3% +$1.51K 0.05% 220
2021
Q2
$509K Buy
+2,149
New +$490K 0.08% 168
2013
Q3
Sell
-2,503
Closed -$215K 109
2013
Q2
$215K Buy
+2,503
New +$208K 0.1% 98

Other funds holding LH

Meristem Family Wealth's LH Position: Q1 2022 in Review

Meristem Family Wealth reduced its Labcorp (LH) stake by 26% in Q1 2022, selling an estimated $130K and leaving 1,603 shares worth $363K. The position accounts for 0.04% of the portfolio, ranked #237.

Meristem Family Wealth first reported a position in LH in Q2 2013 and has held it in 5 quarters since. The position peaked at $582K in Q4 2021. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Meristem Family Wealth held 1,603 shares of Labcorp worth $363K as of Q1 2022.
  • Meristem Family Wealth sold 552 Labcorp shares in Q1 2022, an estimated $130K.
  • Labcorp made up 0.04% of Meristem Family Wealth's portfolio in Q1 2022, its #237 holding.
  • Meristem Family Wealth first reported a position in Labcorp in Q2 2013 and has held it in 5 quarters since.
  • Meristem Family Wealth's Labcorp position peaked at $582K in Q4 2021.
  • 1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.